The strategic partnership will establish a joint solution for the efficient creation of buffers created from concentrates delivered directly to manufacturing facilities, increasing productivity and ...

Helping pharmaceutical companies increase production efficiency and manage risk more effectively NEW YORK & CHICAGO--(BUSINESS WIRE)--Asahi Kasei Bioprocess America, subsidiary of diversified Japanese ...

Biopharmaceutical production depends on buffers. Making sure the right buffer solutions are available, in the right place on the manufacturing line, at the right time, and in the right quantity, is a ...

Asahi Kasei Bioprocess (AKB) provides pharmaceutical and biopharmaceutical manufacturers with a comprehensive suite of tools to maximize safety and improve yields of biotherapeutics during pilot, ...

Waters WAT has introduced new bioprocess walk-up solutions to streamline biologic sample prep and analysis. Notably, the bioprocess walk-up solutions are created by integrating Waters’ BioAccord ...

Pune, India, March 11, 2022 (GLOBE NEWSWIRE) -- The increasing cases of infectious diseases is predicted to create sales opportunities for the market during the forecast period, states Fortune ...

Helping pharmaceutical companies increase production efficiency and manage risk more effectively MOTIV is a buffer management technology for the vast majority of processes in pharmaceutical ...

Asahi Kasei Bioprocess America, subsidiary of diversified Japanese multinational company Asahi Kasei, will be featuring their MOTIV™ Buffer Management Technology at ACHEMA 2022 in Frankfurt this ...

Helping pharmaceutical companies increase production efficiency and manage risk more effectively MOTIV can blend buffers from concentrates in small, single-use bags and is controlled with sensors to ...